# FDA Inspection 1231121 - Sun Pharmaceutical Medicare Limited - February 27, 2024

Source: https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-medicare-limited/d438054a-b0f3-4e2d-a220-67bd22a3fc9b
Source feed: FDA_Inspections

> FDA Inspection 1231121 for Sun Pharmaceutical Medicare Limited on February 27, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231121
- Company Name: Sun Pharmaceutical Medicare Limited
- Inspection Date: 2024-02-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1288660 - 2025-09-19](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-medicare-limited/d859d186-b544-4cdc-8f3d-eaaf40c33379)
- [FDA Inspection 1210949 - 2023-07-13](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-medicare-limited/9be2a665-7c65-442b-91dd-1a12afa5bc54)
- [FDA Inspection 1078834 - 2019-02-05](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-medicare-limited/f16ce15f-424a-4596-92fe-b45d39588c66)
- [FDA Inspection 1018001 - 2017-06-02](https://www.keypedia.com/records/fda_inspections/sun-pharmaceutical-medicare-limited/206753e3-1738-4683-b5bf-0b1885eea446)

Company: https://www.keypedia.com/companies/sun-pharmaceutical-medicare-limited/bcde6f4d-9644-445c-b813-cb49ed881f97

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c